At the last check on Thursday, Guardion Health Sciences Inc.’s (NASDAQ:GHSI) stock traded at $0.15. The average number of shares traded per day over the past five days has been 2,329,086 shares. 2 times new highs have been achieved over the past 5 days, with a $0.0085 gain in that time frame. In the last twenty days, the average volume was 11,020,046, while in the previous 50 days, it was 5,881,783.
Since last month, GHSI stock retreated -2.79%. Shares of the company fell to $0.1390 on 05/24/22, the lowest level in the past month. A 52-week high of $1.98 was reached on 01/04/22 after having rallying from a 52-week low of $0.14. Since the beginning of this year, GHSI’s stock price has dropped by -76.82% or -$0.4946, and marked a new high 2 times. However, the stock has declined by -92.30% since its 52-week high.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Guardion Health Sciences Inc. (GHSI) last reported insider trading activity 296 days ago on Aug 31. Scholtes Bret, the CEO and President of the company, purchased of 5,500 shares for $1.23 on Aug 31. It resulted in a $6,760 investment by the insider. Gagliano Donald A added 5,000 shares at an average price of $1.25 on Aug 30. The insider now owns 27,750 shares following the transaction. On Aug 30, CEO and President Scholtes Bret bought 4,500 shares at $1.26 apiece. The transaction was valued at $5,656.
In the three months ended March 30, Guardion Health Sciences Inc.’s quick ratio stood at 10.80, while its current ratio was 11.30, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 43.80% percent. Based on annual data, GHSI earned $3.11 million in gross profit and brought in $7.23 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -111.00%. Return on equity (ROE) for the past 12 months was -77.20%.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. GHSI’s revenue rose 92.4% to $3.15 million during the quarter, while net income inched up to $2.63 million. While analysts expected Guardion Health Sciences Inc. to report -$0.08 quarterly earnings, the actual figure was -$0.07 per share, beating the consensus estimate by 12.50%. During the quarter, the company generated -$2.3 million in EBITDA. The liabilities of Guardion Health Sciences Inc. were 1.83 million at the end of its most recent quarter ended March 30, and its total debt was $26030.0. The value of shareholders’ equity is $61.43 million.
This quick technical analysis looks at Guardion Health Sciences Inc.’s (GHSI) price momentum. With a historical volatility rate of 69.70%, the RSI 9-day stood at 47.39% on 22 June.
With respect to its five-day moving average, the current Guardion Health Sciences Inc. price is up by +5.90% percent or $0.0085. At present, GHSI shares trade +4.45% above its 20-day simple moving average and -69.62% percent below its 100-day simple moving average. However, the stock is currently trading approximately -26.68% below its SMA50 and -88.45% below its SMA200.
Stochastic coefficient K was 21.42% and Stochastic coefficient D was 13.79%, while ATR was 0.0130. Given the Stochastic reading of 32.89% for the 14-day period, the RSI (14) reading has been calculated as 45.01%.
Guardion Health Sciences Inc. (GHSI) has been rated Buy by analysts. According to 0 brokerage firms, GHSI is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Guardion Health Sciences Inc. stock as buy, with 1 recommending it as overweight.
With a median target price of $0.60, the current consensus forecast for the stock is $0.60 – $0.60. Based on these forecasts, analysts predict Guardion Health Sciences Inc. (GHSI) will achieve an average price target of $0.60.